Health & Pharm General

Newsmatics Brings AI-Powered News Platforms to Czech Republic’s AI Festival for Everyone

🕔9/24/2025 6:58:19 PM

Artificial intelligence has become woven into everyday activities at home and at work, and it plays a growing role across institutions from health care and education to media, robotics and cybersecurity.

Read Full Article

Cearvol Wave Lite: Subtle Design Meets Everyday Comfort in OTC Hearing Aids

🕔9/24/2025 4:15:00 PM

Hearing aids are medical devices, but that doesn't mean they can't also be stylish, discreet, and comfortable. Cearvol's Wave Lite brings a fresh perspective to OTC hearing aids with a design that combines soft fabric texture, balanced color palettes, and ergonomic in-the-ear (ITE) fit.

Read Full Article

WelcomeWare and Raintree Systems Partner to Transform Front Desk Operations in Physical Therapy Practices

🕔9/24/2025 2:17:10 PM

WelcomeWare®, a leader in virtual front desk solutions for healthcare providers, has announced a groundbreaking partnership with Raintree Systems, a leading provider of EMR practice management software for rehabilitation and physical therapy organizations.

Read Full Article

Nanomedicine Market to Reach $393.04 Bn, Globally, by 2030 at 9.2% CAGR

🕔9/24/2025 1:35:44 PM

Nanomedicine Market Trends According to a new report published by Allied Market Research, titled, “Nanomedicine Market by Modality, Application, and Indication: Global Opportunity Analysis and Industry Forecast, 2021–2030,” the global nanomedicine market size was valued at $171,695.

Read Full Article

Microsurgery Market is growing at a CAGR of 6% from 2024 to 2033

🕔9/24/2025 1:21:18 PM

Microsurgery Market Growth The global microsurgery market size was valued at $2.7 billion in 2023, and is projected to reach $4.8 billion by 2033, growing at a CAGR of 6% from 2024 to 2033.

Read Full Article

Botulinum Toxin Market Is Expected to Reach $13.1 Billion by 2031 | CAGR of 8.6%

🕔9/24/2025 1:05:14 PM

Botulinum Toxin Market Growth The global botulinum toxin market size was valued at $5.8 billion in 2021, and is projected to reach $13.1 billion by 2031, growing at a CAGR of 8.

Read Full Article

Adze Biotechnology and King’s College London Announce Clinical Collaboration in hard-to-treat Breast Cancers

🕔9/24/2025 1:00:00 PM

Adze Biotechnology, Inc., a pioneering preclinical-stage company developing systemically deliverable oncolytic immunotherapies, today announced a collaboration with King’s College London to support an investigator-initiated clinical trial evaluating ADZE1.

Read Full Article